𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: A double-blind randomized study

✍ Scribed by T. Thulin; H. Almkvist; L. Berglund; T. Björnsson; B. Fagher; N. Henningsen; M. Honkavaara; V. Naukkarinen; P. Nordenström; J. Sillanpää; K. West

Publisher
Springer US
Year
1994
Tongue
English
Weight
486 KB
Volume
8
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-Blind Randomized Controlled Pilot
Double-Blind Randomized Controlled Pilot Study of the Efficacy and Tolerability of Pirlindole, a Reversible Inhibitor of Monoamine Oxidase A, and Mianserin, in the Treatment of Depression
✍ J. DE WILDE; C. MERTENS; J. VAN DORPE; J. BRUHWYLER; J. GÉCZY 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

This double-blind randomized pilot study aimed to compare the ecacy and the tolerability of pirlindole (150±225 mg/day), a reversible inhibitor of monoamine oxidase A, and mianserin (60±90 mg/day) in the treatment of major depression. Forty patients were included in the trial (20 pirlindole and 20 m

Efficacy and tolerability of duloxetine
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies
✍ Jonathan Davidson; Christer Allgulander; Mark H. Pollack; James Hartford; Janell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of dulo

Efficacy and tolerability of a selective
Efficacy and tolerability of a selective α2C-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: A single-center, double-blind, placebo-controlled, randomized crossover study
✍ Robert A. Wise; Fredrick M. Wigley; Barbara White; Gwen Leatherman; Jianhua Zhon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## Objective OPC‐28326 is a selective α‐adrenergic antagonist with preferential binding to the α~2C~‐adrenergic receptor (α~2C~‐AR) subtype. This study observed the effect of OPC‐28326 on skin temperature and digital blood flow following an acute cold challenge in patients with Raynaud

A multicentre, randomized, double-blind,
A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study
✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre